WITHDRAWN: Th17 Overexpression in Severe COVID-19: A Prospective Observational Study.
Gupta A, Kumar A, Deepak RK, Arora U, Agrawal A, Soneja M, Garg P, Kumar S, Kumar P, Kanga U, V GK, Soni KD, Wig N.
Gupta A, et al. Among authors: kumar s, kumar a, kumar p.
Infect Disord Drug Targets. 2023 May 31. doi: 10.2174/1871526523666230531115839. Online ahead of print.
Infect Disord Drug Targets. 2023.
PMID: 37259933